SCHEMBL2371233

SCHEMBL2371233

Cc1nccn1Cc1cc(NCCN2CCOCC2)nc(Nc2nc3ccc(Br)cc3s2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.45
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
CLK1 P49759 1/20 0.45
EGFR P00533 3/20 0.42
LCK P06239 4/20 0.41
RAF1 P04049 1/20 0.41
BRAF P15056 1/20 0.41
AURKB Q96GD4 1/20 0.41
ABL1 P00519 3/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
BCR P11274 1/20 0.39
LRRK2 Q5S007 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAP3K8 P41279 1/20 0.37
MET P08581 1/20 0.37
RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2370208 0.95 ALDH1A1 (0.44) HTTALDH1A1MAPTCLK1EGFR
SCHEMBL2371227 0.92 APP (0.37) HTTALDH1A1MAPTCLK1EGFR
SCHEMBL2370319 0.80 LMNA (0.42) ALDH1A1MAPTCLK1LCKRXFP1
SCHEMBL2370335 0.80 ALDH1A1 (0.45) HTTALDH1A1MAPTCLK1EGFR
SCHEMBL2369972 0.80 PIK3CG (0.41) ALDH1A1MAPTLCKABL1
SCHEMBL2370365 0.77 ITK (0.47) MAPTEGFRLCKAURKBLRRK2
SCHEMBL2370368 0.77 ITK (0.47) MAPTEGFRLCKAURKBLRRK2
SCHEMBL15673435 0.75 LCK (0.59) HTTALDH1A1MAPTCLK1LCK
SCHEMBL29470510 0.75 LCK (0.59) HTTALDH1A1MAPTCLK1LCK
SCHEMBL2399270 0.75 APP (0.37) HTTALDH1A1MAPTCLK1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011110575-A1 DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2011-09-15 WO disclosed